Navigation Links
Cardiome meldet Veröffentlichung positiver Ergebnisse aus Vergleichsstudie von Vernakalant IV mit Propafenon und Flecainid
Date:9/24/2013

Produkt- und Medikamentenentwicklung beziehen. Vorausschauende Aussagen unterliegen bekannten und unbekannten Risiken, Unwägbarkeiten und sonstigen Faktoren, die dazu führen können, dass sich tatsächliche Ergebnisse, Ereignisse oder Entwicklungen wesentlich von den zukünftigen Ergebnissen, Ereignissen oder Entwicklungen unterscheiden, auf die in vorausschauenden Aussagen implizit oder explizit Bezug genommen wird. Viele dieser Risiken, Unwägbarkeiten und sonstigen Faktoren sind Gegenstand unserer Überlegungen, die den von uns getätigten vorausschauenden Aussagen zugrunde liegen. Hierzu zählen unter anderem folgende: die allgemeinen Wirtschafts- und Geschäftsbedingungen in den Vereinigten Staaten, Kanada, Europa und anderen Regionen, in denen wir vertreten sind; die Marktnachfrage; technologische Veränderungen, die unsere bestehenden Produkte bzw. unsere Fähigkeit zur Entwicklung und Vermarktung zukünftiger Produkte beeinflussen könnten; der Wettbewerb; die bestehende Gesetzgebung und behördliche Bestimmungen, Veränderungen im Zusammenhang mit der bestehenden Gesetzgebung und behördlichen Bestimmungen sowie ein mögliches Nichtbefolgen dieser Vorgaben; die mögliche Kostenerstattung für Produkte und dazugehörige Therapien durch Regierungsstellen und sonstige externe Kostenträger; Nebenwirkungen oder unerwartete Verzögerungen in der präklinischen und klinischen Produktentwicklungsphase; nachteilige Ergebnisse im Zusammenhang mit der Sicherheit und/oder Wirksamkeit unserer Produkte; Entscheidungen von Gesundheitsbehörden bezüglich der Zulassung unserer Technologie und unserer Produkte sowie der jeweilige Zeitpunkt dieser Entscheidungen; der erhebliche Finanzmittelbedarf zur Ausweitung unserer Vermarktungsaktivitäten sowie weitere Faktoren aller Art, die unsere Leistung beeinflussen können. Zudem unterliegt unser Geschäft bestim
'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical Implications of Newly FDA-Approved Treatment for Homozygous Familial Hypercholesterolemia
2. Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... these latent viruses is the Epstein Barr Virus (EBV), and ... (RA) is a chronic inflammatory disease that destroys the body’s ... RA patients have high concentrations of EBV DNA in their ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched Sound ... Patients listen to sound therapy that is tailor-made for ... to months, their tinnitus volume decreases. , AudioNotch has previously ... Notched White Noise. Now, AudioNotch is pleased to announce to ...
(Date:1/14/2014)... Diego, CA (PRWEB) January 14, 2014 ... on the products of cells grown under simulated embryonic ... international license agreement with Suneva Medical, Inc. for physician-dispensed ... (CCM). , This agreement is an amendment ...
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014 ... analyze and research medicinal plants and therapeutic derivatives ... industry, health professionals, and researchers about the challenges ... (Logo: http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8
... Connecticut and SHENZHEN, China, May 15, 2012 ... that a new Roche GS FLX+ System has been successfully ... to complement the existing array of short read sequencing technologies ... GS FLX+ System, developed by 454 Life Sciences, a Roche ...
... small, external bioreactor holding human cells pumped out an ... in a rat with acute inflammation caused by bacterial ... report from researchers at the University of Pittsburgh School ... The findings were published today in the inaugural issue ...
... worse than a shonky pool table with an unseen groove ... study has found that the same goes at the nano-scale, ... "table" made of the semiconductor gallium arsenide. These tiny ... computing technologies. In a research paper titled "The Impact of ...
Cached Biology Technology:BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research 2BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research 3Bio-hybrid device acts as 'thermostat' to control systemic inflammation in sepsis 2You can't play nano-billiards on a bumpy table 2
(Date:4/17/2014)... word for chili peppers. Information about archaeological remains of ... of the appearance of words for chili peppers in ... domesticated and highlight the value of multi-proxy data analysis. ... of nine papers presented in a special feature issue ... Sciences on plant and animal domestication edited by ...
(Date:4/17/2014)... Foundation has been named awardee of a three-year ... Defense Spinal Cord Injury Research Program. Gail Forrest, ... double-blinded, controlled, multi-site clinical trial, which will test ... spinal cord injury. Dr. Forrest is assistant director ... Foundation. Two additional sites will participate - the ...
(Date:4/17/2014)... Professor Marc Andr Gauthier and Professor Luca Razzari ... each been awarded large grants from the John ... for Innovation (CFI) for the acquisition of state-of-the-art ... be added matching grants from the Ministre de ... et de la Technologie (MESRST). These new laboratories ...
Breaking Biology News(10 mins):Chickens to chili peppers 2Chickens to chili peppers 3Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2New state-of-the-art biotech and nanotech equipment for INRS 2
... study at Oregon State University indicates that some past approaches ... the number of live trees that burn up and the ... result. The research was done on the Metolius River ... or 100,000 acres of the area burned in ...
... upspeak: the habit of making a sentence sound like a question? ... as in upspeak may be a sign of superior empathy? ... finds that people use the same brain regions to produce and ... by imitating through so-called mirror neurons. This study shows for the ...
... special edition of the Elsevier journal Ocean Engineering ... an overview of the lessons learned in the aftermath of ... natural disaster in U.S. history. Katrina,s size was larger than ... nearly 93,000 square miles. Katrina,s winds and storm surge overwhelmed ...
Cached Biology News:Effects of forest fire on carbon emissions, climate impacts often overestimated 2Effects of forest fire on carbon emissions, climate impacts often overestimated 3Music in speech equals empathy in heart? 2A forensic analysis of Hurricane Katrina's impact: methods and findings 2
... been designed and created in order to ... genotyping analysis tool. We incorporated the suggestions ... the software. Their main requirements were ease- ... acquisition cost. GeneMarker can perform analysis ...
These stopping screens are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 screens....
... multi-functional program that searches for ... sequence file for polymerase chain ... mutagenesis, and various hybridization applications. ... secondary structure of oligonucleotides based ...
... Expression is a revolutionary new application ... Utilising a novel interface, Expression makes ... incredibly simple. Expression uses the very ... standards in the way sequences are ...
Biology Products: